According to a Research Report Published by Spherical Insights & Consulting, The France Herceptin Market Size is anticipated to Reach USD 165.8 Million by 2035, Growing at a CAGR of 3.10% from 2025 to 2035. The growing prevalence of HER2-positive breast cancer and growing awareness of targeted cancer treatments nationally are the main factors propelling the market.